Actively Recruiting
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
Led by Xuanwu Hospital, Beijing · Updated on 2024-05-30
50000
Participants Needed
1
Research Sites
505 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.
CONDITIONS
Official Title
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of acute ischemic stroke with large- or medium-vessel occlusion according to Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2018
- Informed consent provided by the patient or their surrogate
You will not qualify if you...
- No additional exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
J
Junwei Hao, MD; PhD
CONTACT
G
Gaoting Ma, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here